Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01889316 · ClinicalTrials.gov registry record · NA
Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT01889316 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 75 participants.
The verdict
NCT01889316, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This is a prospective clinical trial involving the use of the FDA-cleared Fetal ECG tracing in labor with the AN24 (Fetal Monitoring device marketed by Monica Healthcare) to the Novii (a newer device also created by Monica Healthcare) using the same technology with different monitor placement.
Interventions
- DEVICE Novii
- DEVICE AN24
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01889316
The ClinicalTrials.gov registry entry for NCT01889316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Novii is the first listed.
NCT01889316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01889316 about?
NCT01889316 is a clinical study titled "Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method". This is a prospective clinical trial involving the use of the FDA-cleared Fetal ECG tracing in labor with the AN24 (Fetal Monitoring device marketed by Monica Healthcare) to the Novii (a newer device also created by Monica Healthcare) using the same technology with different monitor placement.
What is the current status of trial NCT01889316?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2013-04. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01889316?
The interventions under investigation include: Novii (DEVICE), AN24 (DEVICE).
Who is sponsoring clinical trial NCT01889316?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.